Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-authorization safety surveillance of Xyntha in usual care
2008-002456-24Phase 4
- Sponsor
- Wyeth
- Start
- Apr 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of recombinant coagulation factor viii in hemophilia A, sponsored by Wyeth. Primary endpoint: Percentage of subjects with factor VIII inhibitor development.
02
Drugs
recombinant coagulation factor viii
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2008-002456-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002456-24.